Evidence map›Paper›PMID 38562948›Full record

ReviewJSLS : Journal of the Society of Laparoendoscopic Surgeons

Exploring Bariatric Surgery's Impact on Weight Loss and Diabetes: Sodium and Glucose Receptor Modulation.

Austin Cottam, Daniel Cottam, Mitchell Roslin, Amit Surve

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in JSLS : Journal of the Society of Laparoendoscopic Surgeons. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Austin CottamBariatric Medicine Institute, Salt Lake City, Utah, USA. (Drs A. Cottam, D. Cottam, and Surve).
Daniel CottamBariatric Medicine Institute, Salt Lake City, Utah, USA. (Drs A. Cottam, D. Cottam, and Surve).
Mitchell RoslinBariatric Medicine Institute, Salt Lake City, Utah, USA. (Drs A. Cottam, D. Cottam, and Surve).
Amit SurveBariatric Medicine Institute, Salt Lake City, Utah, USA. (Drs A. Cottam, D. Cottam, and Surve).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sodium-glucose cotransporters (SGLT) and glucose transporters (GLUT) have been shown to influence diabetes management by modulating glucose uptake by the intestine. Therefore, alterations in gastrointestinal anatomy during bariatric surgery can change SGLT and GLUT receptor activity. These changes offer an additional mechanism for weight loss and may explain the differential impact of the various bariatric surgical procedures. This review examines the current literature on SGLT and GLUT receptors and their effects on weight loss through genetic studies, pharmacologic inhibition, and how SGLT/GLUT receptors impact surgical physiologic modulation. A better understanding of Type I sodium-glucose cotransport receptors (SGLT-1), GLUT-2, and GLUT-5 could provide insight for improved procedures and allow us to determine the best method to tailor operations to a patient's individual needs.

Indexed as

Bariatric SurgeryDiabetes MellitusReceptors, Cell SurfaceGlucoseHumansSodiumSodium-Glucose Transporter 1Weight LossGlucoseglucose receptorReceptors, Cell SurfaceSodiumSodium-Glucose Transporter 1Bariatric surgeryBariatric surgery pathophysiologyBile acidGLUTObesitySGLT1SGLT2SGLT receptors

Identifiers

PMID38562948
PMCPMC10984375

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.